JFG
EW icon

Jefferies Financial Group’s Edwards Lifesciences EW Stock Holding History

Jefferies Financial Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,800
Closed -$874K – 1730
2024
Q4 		$874K Buy
+11,800
New +$826K 0.01% 927

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Jefferies Financial Group's EW Position: Q1 2026 in Review

Jefferies Financial Group increased its Edwards Lifesciences (EW) stake by 73% in Q1 2026, buying an estimated $1.55M and bringing the position to 44,351 shares worth $3.55M. The position accounts for 0.02% of the portfolio, ranked #425.

Jefferies Financial Group first reported a position in EW in Q1 2023 and has held it in 12 quarters since. The position peaked at $13.6M in Q4 2023. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Jefferies Financial Group held 44,351 shares of Edwards Lifesciences worth $3.55M as of Q1 2026.
  • Jefferies Financial Group bought 18,762 Edwards Lifesciences shares in Q1 2026, an estimated $1.55M.
  • Edwards Lifesciences made up 0.02% of Jefferies Financial Group's portfolio in Q1 2026, its #425 holding.
  • Jefferies Financial Group first reported a position in Edwards Lifesciences in Q1 2023 and has held it in 12 quarters since.
  • Jefferies Financial Group's Edwards Lifesciences position peaked at $13.6M in Q4 2023.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.